Target type: cellularcomponent
A synapse of a climbing fiber onto the dendrites of a Purkinje cell in cerebellum. The climbing fiber originates from the inferior olivary nucleus of the medulla oblongata. [GOC:aruk, GOC:bc, PMID:19597563, PMID:23811844, PMID:5044254]
The cerebellar climbing fiber to Purkinje cell synapse is a specialized junction between two types of neurons in the cerebellum. Climbing fibers originate from the inferior olive in the brainstem and form highly complex, one-to-one connections with Purkinje cells, the sole output neurons of the cerebellar cortex. This synapse is characterized by its unique structure and function, playing a critical role in motor learning and coordination.
**Presynaptic Terminal:**
* The climbing fiber terminal, upon reaching the Purkinje cell, forms a large, complex structure that wraps around the dendritic tree of the Purkinje cell.
* This terminal is filled with numerous synaptic vesicles containing neurotransmitters, primarily glutamate.
* The terminal also contains mitochondria, providing energy for the process of neurotransmission.
**Postsynaptic Dendrite:**
* The Purkinje cell dendrite receives input from both climbing fibers and parallel fibers, another type of cerebellar neuron.
* The postsynaptic membrane of the Purkinje cell dendrite contains specialized receptors, specifically AMPA and NMDA receptors, that bind to glutamate released by the climbing fiber.
* These receptors mediate the excitatory postsynaptic potential (EPSP) generated by the climbing fiber input.
**Synaptic Transmission:**
* When an action potential arrives at the climbing fiber terminal, it triggers the opening of voltage-gated calcium channels.
* This influx of calcium ions leads to the fusion of synaptic vesicles with the presynaptic membrane, releasing glutamate into the synaptic cleft.
* Glutamate then binds to AMPA and NMDA receptors on the Purkinje cell dendrite, activating these receptors and generating a strong, complex EPSP.
**Functional Significance:**
* The climbing fiber to Purkinje cell synapse is vital for motor learning and coordination.
* It plays a crucial role in error detection and correction during motor movements.
* The strong, complex EPSP generated by the climbing fiber input is thought to induce long-term depression (LTD) in the parallel fiber to Purkinje cell synapses, contributing to the plasticity of cerebellar circuits.
**Overall, the climbing fiber to Purkinje cell synapse is a highly specialized and crucial junction that plays a critical role in cerebellar function, motor learning, and coordination.**'
"
Protein | Definition | Taxonomy |
---|---|---|
Sortilin | A sortilin that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q99523] | Homo sapiens (human) |
Integrin beta-1 | An integrin beta-1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P05556] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
haloperidol | haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety. Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
1,3-ditolylguanidine | 1,3-ditolylguanidine: structure given in first source; a selective ligand for the sigma binding sites in the brain | toluenes | |
tirofiban | tirofiban : A member of the class of piperidines that is L-tyrosine in which a hydrogen attached to the amino group is replaced by a butylsulfonyl group and in which the hydrogen attached to the phenolic hydroxy group is replaced by a 4-(piperidin-4-yl)butyl group. Tirofiban: Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in the treatment of ACUTE CORONARY SYNDROME. | L-tyrosine derivative; piperidines; sulfonamide | anticoagulant; fibrin modulating drug; platelet glycoprotein-IIb/IIIa receptor antagonist |
arginyl-glycyl-aspartic acid | arginyl-glycyl-aspartic acid: amino acid sequence of basic unit of widespread cellular recognition system | oligopeptide | |
arginyl-glycyl-aspartyl-serine | arginyl-glycyl-aspartyl-serine: corresponds to cell attachment site of fibronectin; located near carboxyl-terminal region of alpha-chain of fibrinogen; inhibits platelet aggregation & fibrinogen binding to activated platelets | ||
sr 48692 | SR 48692: structure in first source; a neurotensin receptor-1 antagonist | N-acyl-amino acid | |
glycyl-arginyl-glycyl-aspartyl-serine | glycyl-arginyl-glycyl-aspartyl-serine: synthetic peptide from fibronectins; inhibits experimental metastasis of murine melanoma cells | ||
d-arg-gly-asp-trp | arginyl-glycyl-aspartyl-tryptophan: a synthetic RGD-containing peptide | ||
l 738167 | L 738167: structure in first source | ||
cilengitide | Cilengitide: an alphaVbeta3 integrin antagonist that paralyzes cancer cells | oligopeptide | |
l 734217 | L 734217: fibrinogen receptor antagonist; structure given in first source | ||
cyclopamine | piperidines | glioma-associated oncogene inhibitor | |
arginyl-glycyl-aspartyl-phenylalanine | |||
cyclic(arg-gly-asp-d-phe-val) | |||
mk-0429 | |||
mocetinostat | mocetinostat : A benzamide obtained by formal condensation of the carboxy group of 4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an orally active and isotype-selective HDAC inhibitor which exhibits antitumour activity (IC50 = 0.15, 0.29, 1.66 and 0.59 muM for HDAC1, HDAC2, HDAC3 and HDAC11). mocetinostat: undergoing phase II clinical trials for treatment of cancer | aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline | antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent |
tr 14035 | N-(2,6-dichlorobenzoyl)-4-(2',6'-bismethoxyphenyl)phenylalanine: TR-14035 is the (L)-isomer; an antagonist of both alpha4beta1 and beta7 integrins; structure in first source | ||
bio 1211 | BIO 1211: integrin alpha4beta1 inhibitor; structure in first source | ||
neurotensin | neurotensin, Tyr(11)-: RN given refers to parent cpd & (D)-isomer; RN for cpd without isomeric designation not avail 5/91 | peptide hormone | human metabolite; mitogen; neurotransmitter; vulnerary |
af38469 |